These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pioglitazone: in vitro effects on rat hepatoma cells and in vivo liver hypertrophy in KKAy mice. Weinstock RS; Murray FT; Diani A; Sangani GA; Wachowski MB; Messina JL Pharmacology; 1997 Apr; 54(4):169-78. PubMed ID: 9211562 [TBL] [Abstract][Full Text] [Related]
6. Effects of troglitazone and pioglitazone on cytokine-mediated endothelial cell proliferation in vitro. Gralinski MR; Rowse PE; Breider MA J Cardiovasc Pharmacol; 1998 Jun; 31(6):909-13. PubMed ID: 9641476 [TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative activity of oral anti-hyperglycemic agents on human vascular smooth muscle cells: thiazolidinediones (glitazones) have enhanced activity under high glucose conditions. Little PJ; Osman N; de Dios ST; Cemerlang N; Ballinger M; Nigro J Cardiovasc Diabetol; 2007 Oct; 6():33. PubMed ID: 17963526 [TBL] [Abstract][Full Text] [Related]
8. Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats. Iida KT; Kawakami Y; Suzuki M; Shimano H; Toyoshima H; Sone H; Shimada K; Iwama Y; Watanabe Y; Mokuno H; Kamata K; Yamada N Am J Physiol Endocrinol Metab; 2003 Jun; 284(6):E1125-30. PubMed ID: 12569086 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory activity of clinical thiazolidinedione peroxisome proliferator activating receptor-gamma ligands toward internal mammary artery, radial artery, and saphenous vein smooth muscle cell proliferation. de Dios ST; Bruemmer D; Dilley RJ; Ivey ME; Jennings GL; Law RE; Little PJ Circulation; 2003 May; 107(20):2548-50. PubMed ID: 12742988 [TBL] [Abstract][Full Text] [Related]
10. Pioglitazone attenuates hypertension and inhibits growth of renal arteriolar smooth muscle in rats. Dubey RK; Zhang HY; Reddy SR; Boegehold MA; Kotchen TA Am J Physiol; 1993 Oct; 265(4 Pt 2):R726-32. PubMed ID: 8238439 [TBL] [Abstract][Full Text] [Related]
11. Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells. Asano M; Nakajima T; Iwasawa K; Morita T; Nakamura F; Imuta H; Chisaki K; Yamada N; Omata M; Okuda Y Br J Pharmacol; 1999 Oct; 128(3):673-83. PubMed ID: 10516648 [TBL] [Abstract][Full Text] [Related]
12. Sildenafil does not enhance but rather attenuates vasorelaxant effects of antidiabetic agents. Peuler JD; Phelps LE J Smooth Muscle Res; 2015; 51():22-36. PubMed ID: 26004378 [TBL] [Abstract][Full Text] [Related]
13. Differential block by troglitazone and rosiglitazone of glibenclamide-sensitive K(+) current in rat aorta myocytes. Mishra SK; Aaronson PI Eur J Pharmacol; 1999 Dec; 386(1):121-5. PubMed ID: 10611472 [TBL] [Abstract][Full Text] [Related]
14. Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments. Lenhard JM; Croom DK; Minnick DT Biochem Biophys Res Commun; 2004 Nov; 324(1):92-7. PubMed ID: 15464987 [TBL] [Abstract][Full Text] [Related]
15. Metformin but not glyburide prevents high glucose-induced abnormalities in relaxation and intracellular Ca2+ transients in adult rat ventricular myocytes. Ren J; Dominguez LJ; Sowers JR; Davidoff AJ Diabetes; 1999 Oct; 48(10):2059-65. PubMed ID: 10512374 [TBL] [Abstract][Full Text] [Related]
16. Effect of pioglitazone on vascular reactivity in vivo and in vitro. Kotchen TA; Zhang HY; Reddy S; Hoffmann RG Am J Physiol; 1996 Mar; 270(3 Pt 2):R660-6. PubMed ID: 8780234 [TBL] [Abstract][Full Text] [Related]
17. Differential effects of 3 classes of antidiabetic drugs on olanzapine-induced glucose dysregulation and insulin resistance in female rats. Boyda HN; Procyshyn RM; Tse L; Hawkes E; Jin CH; Pang CC; Honer WG; Barr AM J Psychiatry Neurosci; 2012 Nov; 37(6):407-15. PubMed ID: 22640703 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the atherogenic properties of vascular smooth muscle proteoglycans by oral anti-hyperglycemic agents. de Dios ST; Frontanilla KV; Nigro J; Ballinger ML; Ivey ME; Cawson EA; Little PJ J Diabetes Complications; 2007; 21(2):108-17. PubMed ID: 17331859 [TBL] [Abstract][Full Text] [Related]
19. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Brunmair B; Staniek K; Gras F; Scharf N; Althaym A; Clara R; Roden M; Gnaiger E; Nohl H; Waldhäusl W; Fürnsinn C Diabetes; 2004 Apr; 53(4):1052-9. PubMed ID: 15047621 [TBL] [Abstract][Full Text] [Related]
20. Cardioprotection with pioglitazone is abolished by nitric oxide synthase inhibitor in ischemic rabbit hearts--comparison of the effects of pioglitazone and metformin. Kawabata H; Ishikawa K Diabetes Metab Res Rev; 2003; 19(4):299-305. PubMed ID: 12879407 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]